Valuation: Psychemedics Corporation

Market Cap 9.79M 8.46M 7.96M 7.23M 13.6M 938M 13.8M 93.33M 36.58M 469M 36.76M 35.96M 1.56B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.24M 7.75M 7.05M 13.25M 914M 13.45M 90.94M 35.64M 457M 35.82M 35.04M 1.52B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
6 months+57.89%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
4.99
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 16/08/2023
Director of Finance/CFO 36 26/11/2023
Corporate Officer/Principal 40 20/09/2023
Director TitleAgeSince
Director/Board Member 64 15/03/2021
Director/Board Member 58 03/04/2022
Director/Board Member 64 11/08/2022
Date Insider Type Main position Quantity % Market Cap.
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+4.80%-48.28% 15.24M
-0.12%+0.53%+95.08%+497.66% 45.29B
+1.00%+1.34%+20.79%+52.37% 26.22B
+0.92%+2.77%-18.66%-28.13% 8.01B
-1.85%-2.24%+12.58%+151.03% 5.98B
+1.28%-2.69%+13.59%+68.39% 3.28B
-1.78%-7.14%-39.71%+1,464.95% 2.31B
-2.10%-4.11%+154.01%+16.97% 2.08B
-0.38%-6.49%-4.05%-56.15% 2B
-0.44%-2.26%+28.23%+19.70% 1.9B
Average -0.35%-0.88%+26.67%+213.85% 9.71B
Weighted average by Cap. +0.12%-0.32%+52.48%+290.01%

Financials

2023 2024
Net sales 22.1M 19.09M 17.96M 16.32M 30.7M 2.12B 31.15M 211M 82.55M 1.06B 82.97M 81.17M 3.53B 19.68M 17M 16M 14.54M 27.35M 1.89B 27.75M 188M 73.54M 943M 73.91M 72.3M 3.14B
Net income -4.15M -3.59M -3.38M -3.07M -5.77M -398M -5.86M -39.6M -15.52M -199M -15.6M -15.26M -663M -1.86M -1.61M -1.51M -1.37M -2.59M -178M -2.62M -17.74M -6.95M -89.18M -6.99M -6.84M -297M
Net Debt 334K 288K 271K 247K 464K 32M 471K 3.18M 1.25M 16.01M 1.25M 1.23M 53.31M -251K -217K -204K -185K -349K -24.05M -354K -2.39M -938K -12.03M -942K -922K -40.06M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock